Abstract:Pancreatic cancer (PC) is one of the most fatal malignancies in the world. This lethality persists due to lack of effective and efficient treatment strategies. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive epithelial malignancy which has a high incidence rate and contributes to overall cancer fatalities. As of 2022, pancreatic cancer contributes to about 3 % of all cancers globally. Over the years, research has characterised germline predisposition, the origin cell, precursor lesions, genetic alterations, structural alterations, transcriptional changes, tumour heterogeneity, metastatic progression, and the tumour microenvironment, which has improved the understanding of PDAC carcinogenesis. By using molecular-based target therapies, these fundamental advancements support primary prevention, screening, early detection, and treatment. The focus of this review is the use of targeted nanoparticles as an alternative to conventional pancreatic cancer treatment due to the various side effects of the latter. The principles of nanoparticle based cancer therapy is efficient targeting of tumour cells via enhanced permeability and retention (EPR) effects and decrease the chemotherapy side effects due to their non-specificity. To increase the efficiency of existing therapies and modify target nanoparticles, several molecular markers of pancreatic cancer cells have been identified. Thus pancreatic cancer cells can be detected using appropriately functionalized nanoparticles with specific signalling molecules. Once cancer has been identified, these nanoparticles can kill the tumour by inducing hyperthermia, medication delivery, immunotherapy or gene therapy. As potent co-delivery methods for adjuvants and tumor-associated antigens; nanoparticles (NPs) have demonstrated significant promise as delivery vehicles in cancer therapy. This ensures the precise internalization of the functionalized nanoparticle and thus also activates the immune system effectively against tumor cells. This review also discusses the immunological factors behind the uptake of functionalized nanoparticles in cancer therapies. Theranostics, which combine imaging and therapeutic chemicals in a single nanocarrier, are the next generation of medicines. Pancreatic cancer treatment may be revolutionised by the development of a tailored nanocarrier with diagnostic, therapeutic, and imaging capabilities. It is extremely difficult to incorporate various therapeutic modalities into a single nanocarrier without compromising the individual functionalities. Surface modification of nanocarriers with antibodies or proteins will enable to attain multifunctionality which increases the efficiency of pancreatic cancer therapy.

Nanomaterials: Applications in the Diagnosis and Treatment of Pancreatic Cancer.

The Application of Nanomaterials in the Treatment of Pancreatic-Related Diseases

Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.

Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma

The Application of Bio-Nanotechnology in Tumor Diagnosis and Treatment: A View

Nanoparticles for Improving Cancer Diagnosis.

The New Era of Pancreatic Cancer Treatment: Application of Nanotechnology Breaking Through Bottlenecks

Advanced Iron Oxide Nanotheranostics for Multimodal and Precision Treatment of Pancreatic Ductal Adenocarcinoma

Nanomedicines Enhance Minimally Invasive Therapy of Pancreatic Cancer

Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer

Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Prospect of Gold Nanoparticles in Pancreatic Cancer

Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging

Theranostic nanoparticles for detection and treatment of pancreatic cancer

Current Progress in Cancer Treatment Using Nanomaterials

Nanomaterials in Cancer Treatment

Recent advances in nanomaterials for prostate cancer detection and diagnosis

Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment

Nanomaterials for cancer therapy: current progress and perspectives

Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.